This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of other and unspecified sites
CD2_INSITU_OTHER_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ locis aliis sive non specificatis
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- In situ neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1176 | 236 | 940 |
| Unadjusted period prevalence (%) | 0.35 | 0.08 | 0.41 |
| Median age at first event (years) | 71.36 | 68.13 | 72.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1088
- Matched controls
- 10878
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KCD02
NOMESCO Finland
Transurethral resection of bladder
1013.3
323.0
698
19
UKC02
NOMESCO Finland
Cystoscopy
115.5
323.0
1023
1303
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
2297.9
323.0
500
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
323.0
711
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
6889.6
323.0
439
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
323.0
311
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
323.0
672
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
528.1
323.0
589
24
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
156.5
297.6
305
27
R31
ICD-10 Finland
Unspecified haematuria
14.9
296.9
579
772
C61
ICD-10 Finland
Malignant neoplasm of prostate
336.6
197.1
194
7
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2269.8
191.4
180
*
ZX136
NOMESCO Finland
Intravesicalis
196.9
177.7
181
11
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
190.4
172.3
176
11
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
+∞
141.8
133
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
50.7
126.9
153
35
WX320
NOMESCO Finland
Spinalanesthesy
4.8
112.4
493
1597
130
Kela drug reimbursment
Malignant tumour
+∞
111.4
105
*
XKD00
NOMESCO Finland
Uroflowmetry
4.7
106.9
468
1495
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
92.0
87
*
116
Kela drug reimbursment
Prostate cancer
+∞
92.0
87
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.6
89.5
386
1172
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
+∞
87.7
83
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.0
84.0
432
1528
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
+∞
82.3
78
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.3
77.1
200
325
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
71.6
75.6
86
13
TKC20
NOMESCO Finland
Catheterisation of bladder
6.0
73.8
225
453
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
69.5
66
*
KCW96
NOMESCO Finland
Other operations on bladder
65.3
68.5
79
13
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
33.6
64.1
84
27
U06
ICPC
Haematuria
11.2
62.4
122
121
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
325.2
61.0
61
*
L02AE02
ATC
leuprorelin; implant, parenteral
218.8
60.7
62
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
66.8
60.1
69
11
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
59.9
57
*
WF002
NOMESCO Finland
Radical radiotherapy
319.4
59.9
60
*
JN4AD
NOMESCO Finland
Body CT examination
8.0
57.2
136
190
WX402
NOMESCO Finland
General anaesthesia
4.3
56.3
236
657
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
54.6
52
*
A04AA02
ATC
granisetron; systemic, transdermal
192.7
53.4
55
*
JN4BD
NOMESCO Finland
Extensive body CT
6.2
52.4
150
272
H02AB02
ATC
dexamethasone; systemic
21.2
51.7
77
39
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
185.4
51.4
53
*
ZXC20
NOMESCO Finland
Use of chemical agents
20.1
50.8
77
41
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
50.4
48
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
49.3
47
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
488.0
47.7
47
*
WX224
NOMESCO Finland
Blockade of obturius nerve
+∞
47.2
45
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.4
46.7
187
491
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
46.5
260
910
J01MA02
ATC
ciprofloxacin; systemic
2.5
45.6
548
3112
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
466.2
45.6
45
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
44.4
345
1514
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
43.0
41
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.5
42.9
228
763
UKB02
NOMESCO Finland
Retrograde ureteroscopy
16.7
42.7
69
44
L02BB03
ATC
bicalutamide; oral
+∞
41.9
40
*
KCC10
NOMESCO Finland
Cystoprostatectomy
422.7
41.4
41
*
Y77
ICPC
Malignant neoplasm prostate
+∞
40.9
39
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
411.9
40.4
40
*
KH1AD
NOMESCO Finland
CT of urinary organs
7.0
38.9
100
155
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
11.1
38.8
75
72
ZXC15
NOMESCO Finland
Use of photodynamic technique
23.1
38.2
55
25
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
15.0
38.1
64
45
4CX01
NOMESCO Finland
NA
+∞
37.7
36
*
N30.0
ICD-10 Finland
Acute cystitis
3.6
37.1
186
589
KCB00
NOMESCO Finland
Biopsy of bladder
80.9
35.0
39
5
XX3DW
NOMESCO Finland
Time consuming IT work
5.2
34.6
113
237
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
34.6
33
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
347.4
34.1
34
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
33.5
32
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
175.2
32.9
34
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
32.4
31
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
31.4
30
*
R33
ICD-10 Finland
Retention of urine
3.2
31.3
184
652
WZC30
NOMESCO Finland
Teaching
3.4
31.2
167
553
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.3
30.5
58
54
U76
ICPC
Malignant neoplasm of bladder
+∞
30.3
29
*
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
+∞
30.3
29
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
30.2
209
824
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.6
30.1
91
174
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
310.5
29.9
30
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.5
29.7
66
82
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
106.2
28.8
31
*
KC1GB
NOMESCO Finland
Cystography with X-ray
65.8
28.1
32
5
KED22
NOMESCO Finland
Transurethral resection of prostate
3.1
27.1
168
614
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.4
26.9
83
163
G04BD12
ATC
mirabegron; oral
2.9
26.8
178
681
JN4CD
NOMESCO Finland
Very extensive body CT
7.1
26.8
67
100
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
26.1
25
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
26.1
25
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
9.4
26.0
54
60
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
24.8
25.8
36
15
J01MA12
ATC
levofloxacin; systemic
2.4
25.7
258
1246
Z51.5
ICD-10 Finland
Palliative care
6.2
25.6
71
122
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
25.1
24
*
115
Kela drug reimbursment
Breast cancer
+∞
25.1
24
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
92.2
24.7
27
*
J01EA01
ATC
trimethoprim; systemic
2.4
24.7
241
1144
ZX090
NOMESCO Finland
Other technic of radiotherapy
133.0
24.7
26
*
G04CA02
ATC
tamsulosin; oral
2.0
24.1
470
3022
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.2
23.7
58
84
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
23.0
22
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
23.0
22
*
WF004
NOMESCO Finland
Palliative radiotherapy
234.6
22.7
23
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
22.5
911
7626
NK6AN
NOMESCO Finland
Total body bone isotope imaging
53.2
22.2
26
5
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
21.9
21
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
21.9
527
3620
KH1DD
NOMESCO Finland
CT urography of urinary organs
81.8
21.7
24
*
A04AA01
ATC
ondansetron; systemic, rectal
8.3
21.6
48
60
KDV10
NOMESCO Finland
Internal urethrotomy
7.5
21.5
51
71
B01AB10
ATC
tinzaparin; parenteral
4.4
21.4
79
188
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
20.9
20
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
42.5
20.5
25
6
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
9.4
20.0
41
45
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
19.8
19
*
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
+∞
19.8
19
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
19.8
19
*
B02AA02
ATC
tranexamic acid; systemic
3.1
19.8
116
403
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
46.9
19.2
23
5
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.5
18.8
41
50
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
18.8
18
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
18.8
18
*
L01BC06
ATC
capecitabine; oral
+∞
18.8
18
*
B01AB05
ATC
enoxaparin; parenteral
2.0
18.7
319
1907
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
18.6
110
385
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
101.8
18.6
20
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
193.1
18.6
19
*
A98
ICPC
Health maint/preventive medicine
2.4
18.1
990
8794
A04AA55
ATC
palonosetron, combinations; systemic
+∞
17.7
17
*
KCD30
NOMESCO Finland
Destruction of tumour of bladder
+∞
17.7
17
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
96.6
17.6
19
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
96.6
17.6
19
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
17.5
137
573
J01DB01
ATC
cefalexin; oral
1.8
17.3
824
6832
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.9
17.1
72
195
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.7
16.9
75
212
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
16.7
16
*
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
16.7
16
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
16.7
16
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
16.7
16
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
172.4
16.5
17
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.3
16.4
162
763
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.6
16.2
57
130
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
7.8
16.2
37
49
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
48.2
16.1
19
*
L02BG04
ATC
letrozole; oral
48.2
16.1
19
*
KDE20
NOMESCO Finland
Removal of foreign body from urethra
18.8
16.0
24
13
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
+∞
15.7
15
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
15.7
15
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
162.1
15.5
16
*
ZXC96
NOMESCO Finland
Robot assisted procedure
16.7
14.8
23
14
SPAT1167
SPAT
Insertion of urinary catheter
3.5
14.8
70
210
SPAT1262
SPAT
Handing over of treatment supplies
1.9
14.7
243
1418
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
14.6
14
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
14.6
14
*
D09.1
ICD-10 Finland
Carcinoma in situ: Other and unspecified urinary organs
+∞
14.6
14
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
14.6
14
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
14.6
14
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
SPAT1263
SPAT
Sampling
1.7
14.5
446
3170
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
151.9
14.5
15
*
L03AA13
ATC
pegfilgrastim; parenteral
151.9
14.5
15
*
KBH20
NOMESCO Finland
Replantation of ureter
151.9
14.5
15
*
KA3EB
NOMESCO Finland
Antegrade pyelography
36.5
14.5
18
5
A02BC02
ATC
pantoprazole; systemic
1.7
14.2
661
5261
WX110
NOMESCO Finland
Local anesthesy
1.6
14.2
620
4848
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
13.9
96
372
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
54.0
13.8
16
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.5
13.7
48
110
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
76.1
13.6
15
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
13.6
13
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
13.6
13
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
13.6
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.6
13
*
D09.9
ICD-10 Finland
Carcinoma in situ, unspecified
141.6
13.5
14
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
141.6
13.5
14
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
141.6
13.5
14
*
N30.9
ICD-10 Finland
Cystitis, unspecified
3.5
13.5
62
182
SPAT1153
SPAT
Removal of sutures
1.7
13.1
345
2331
L03AA02
ATC
filgrastim; parenteral
50.6
12.9
15
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
12.5
113
508
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
12.5
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.5
12
*
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
12.5
12
*
S18
ICPC
Laceration/cut
1.6
12.4
446
3272
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
12.3
226
1358
KBV10
NOMESCO Finland
Removal of stent from ureter
11.2
12.1
22
20
G04CA01
ATC
alfuzosin; oral
1.8
11.9
221
1334
G04BE03
ATC
sildenafil; oral
11.9
11.8
21
18
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
11.5
11
*
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
11.5
11
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
11.5
11
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
11.5
11
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
11.5
11
*
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
11.5
11
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
11.5
11
*
KBD00
NOMESCO Finland
Partial excision of ureter
121.2
11.4
12
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
121.2
11.4
12
*
KA1FN
NOMESCO Finland
Isotope renography
15.2
11.3
18
12
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
11.2
450
3365
TJF80
NOMESCO Finland
Ostomy education
17.2
11.2
17
10
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.0
11.1
63
215
TKC22
NOMESCO Finland
Catheterisation instruction
4.1
11.1
42
105
SPAT1125
SPAT
Stoma care and guidance
7.2
11.1
26
37
WW500
NOMESCO Finland
Blood transfusion
4.3
10.8
39
93
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
21.7
10.7
15
7
N02AA05
ATC
oxycodone; systemic
2.0
10.5
133
696
XJH00
NOMESCO Finland
Transanal ultrasonography
2.2
10.5
107
510
U29
ICPC
Urinary symptom/complaint other
3.9
10.5
42
111
L02BA01
ATC
tamoxifen; oral
111.0
10.4
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
111.0
10.4
11
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
10.4
10
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
10.4
10
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
10.4
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
10.4
10
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
10.4
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.4
10
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
10.4
10
*
R39.1
ICD-10 Finland
Other difficulties with micturition
3.0
10.4
59
202
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.2
10.4
16
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
10.1
130
685
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.9
259
1721
SPAT1312
SPAT
General health counselling
1.6
9.8
313
2197
U07
ICPC
Urine symptom/complaint other
2.5
9.7
76
319
L57.0
ICD-10 Finland
Actinic keratosis
2.2
9.7
101
487
G03HA01
ATC
cyproterone; systemic
55.5
9.7
11
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
9.6
77
324
ZXC50
NOMESCO Finland
Cryotherapy
4.1
9.6
36
90
ZX120
NOMESCO Finland
Intravenous
2.3
9.6
88
399
U05
ICPC
Urination problems other
2.6
9.4
68
273
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
100.8
9.4
10
*
A04AD12
ATC
aprepitant; systemic
100.8
9.4
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
17.7
9.4
14
8
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
9.4
54
188
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
+∞
9.4
9
*
L02BX02
ATC
degarelix; parenteral
+∞
9.4
9
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
9.4
9
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
9.4
9
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
9.4
9
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
9.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
L02BX03
ATC
abiraterone; oral
+∞
9.4
9
*
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
9.4
9
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
9.4
9
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
9.4
9
*
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
+∞
9.4
9
*
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
9.3
392
2928
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
10.8
9.3
17
16
J01CA08
ATC
pivmecillinam; oral
1.7
9.3
206
1306
G04BD08
ATC
solifenacin; oral
2.2
9.1
88
412
KBV00
NOMESCO Finland
Insertion of stent into ureter
10.1
9.0
17
17
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
37.0
9.0
11
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.8
8.6
27
57
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
16.4
8.6
13
8
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
8.5
421
3245
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.7
8.5
23
41
ZX112
NOMESCO Finland
Subcutaneous
7.9
8.4
18
23
L02AE04
ATC
triptorelin; parenteral
+∞
8.3
8
*
L02BB04
ATC
enzalutamide; oral
+∞
8.3
8
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
8.3
8
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
8.3
8
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
8.3
8
*
7323
FHL
Electrosection of TU bladder wall change
+∞
8.3
8
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
8.3
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.3
8
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
8.3
8
*
D09.7
ICD-10 Finland
Carcinoma in situ of other specified sites
+∞
8.3
8
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
8.3
8
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
8.2
108
576
GD1AD
NOMESCO Finland
Thorax CT examination
2.8
8.1
51
187
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
8.1
38
116
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
8.1
141
828
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.2
8.0
29
71
R50.9
ICD-10 Finland
Fever, unspecified
1.9
7.8
123
698
A79
ICPC
Malignancy NOS
45.3
7.7
9
*
U01
ICPC
Dysuria/painful urination
2.6
7.7
56
226
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.8
7.7
24
51
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
11.9
7.6
13
11
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
25.2
7.6
10
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.5
7.5
21
39
WX702
NOMESCO Finland
Supraglottic ventilation device
2.6
7.5
52
205
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
80.6
7.4
8
*
TKC00
NOMESCO Finland
Needle biopsy of bladder
80.6
7.4
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
80.6
7.4
8
*
KBB00
NOMESCO Finland
Biopsy of ureter
80.6
7.4
8
*
KGH10
NOMESCO Finland
Operation for phimosis
2.9
7.4
42
146
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
7.3
32
93
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.3
7
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
7.3
7
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
7.3
7
*
L01CA04
ATC
vinorelbine; systemic
+∞
7.3
7
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
UJF32
NOMESCO Finland
Coloscopy
1.5
7.2
246
1734
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
7.2
81
404
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
20.2
7.1
10
5
UKD02
NOMESCO Finland
Urethroscopy
7.0
7.0
16
23
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
3.8
7.0
28
76
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
5.0
7.0
21
43
U02
ICPC
Urinary frequency/urgency
1.9
6.9
107
604
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
13.9
6.9
11
8
KE1BG
NOMESCO Finland
MRI of prostate
13.9
6.9
11
8
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
6.9
79
397
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.9
351
2697
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.8
195
1316
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
6.7
48
194
KEB00
NOMESCO Finland
Biopsy of prostate
7.2
6.7
15
21
N21.0
ICD-10 Finland
Calculus in bladder
4.0
6.7
25
64
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.7
465
3774
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
6.7
156
1000
XQ848
NOMESCO Finland
Dermatological photography
3.4
6.7
30
90
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
6.7
328
2496
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
6.6
44
171
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.6
453
3666
A06AH03
ATC
naloxegol; oral
12.3
6.6
11
9
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.5
6.5
47
191
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
6.5
83
436
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
5.1
6.5
19
38
HA1AA
NOMESCO Finland
X-ray mammography
4.0
6.5
24
61
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
6.5
160
1042
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
70.2
6.4
7
*
U13
ICPC
Bladder symptom/complaint other
3.1
6.4
32
104
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.7
6.4
26
72
SPAT1301
SPAT
No procedures
1.4
6.3
323
2470
ZZR00
NOMESCO Finland
Flap of skin
6.0
6.3
16
27
WX882
NOMESCO Finland
High dependency care
3.0
6.3
34
117
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.3
6
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
6.3
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
KCC00
NOMESCO Finland
Cystectomy
+∞
6.3
6
*
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
6.3
6
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
6.3
6
*
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
6.3
6
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
6.2
82
437
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.1
299
2270
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
8.6
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
629
2024
5.53
188.47
6.6
2.4
3.7
3.7
e6/l
0.02
586
1760
736
2883
5.15
168.11
11.1
3.1
504.9
108.6
e6/l
1.60
676
2246
676
2629
4.70
151.72
10.3
3.0
0.2
0.5
e6/l
5.98
594
1996
759
3276
4.71
146.70
12.2
3.5
160.0
98.6
e6/l
0.99
703
2390
1046
5940
7.88
139.23
14.4
4.2
52.4
1891.4
e6/l
1.21
26
104
784
3929
3.99
112.01
5.9
3.7
—
—
—
0
0
422
1490
3.86
100.35
10.4
2.9
1.1
1.4
e6/l
0.56
348
849
441
1617
3.76
98.92
9.4
2.7
1.0
1.0
e6/l
0.03
366
966
743
4409
2.86
65.03
6.4
3.5
0.0
0.0
estimate
0.00
201
781
741
4392
2.86
64.98
8.3
4.7
0.0
0.0
estimate
0.00
201
786
189
507
4.25
63.90
3.7
1.4
24.9
3.7
ug/l
0.92
157
383
197
546
4.13
63.72
8.5
2.6
0.2
0.3
e6/l
1.13
197
537
744
4473
2.81
62.50
6.4
3.5
0.0
0.0
estimate
0.00
192
750
867
5683
3.00
61.02
5.8
4.7
6.9
7.0
mmol/l
0.63
843
5314
707
4490
2.44
47.56
7.3
4.0
10.7
13.2
umol/l
12.77
678
4211
396
1996
2.48
43.97
3.2
2.2
—
—
—
0
0
931
6918
2.66
41.30
9.4
5.4
79.6
78.3
u/l
0.38
884
6358
611
3957
2.13
35.09
6.0
3.8
34.1
35.0
g/l
3.30
570
3614
1079
8916
3.55
34.56
24.2
14.8
31.4
26.9
mg/l
3.70
941
7078
690
4722
2.12
33.75
8.0
5.7
1.2
1.2
mmol/l
0.61
577
3961
1037
8440
2.93
32.92
26.0
13.8
70.7
73.7
ml/min/173m2
4.85
948
6824
688
4777
2.06
31.44
9.7
6.0
4.7
4.5
e9/l
0.67
598
4120
538
3433
2.05
30.91
7.2
3.7
—
—
—
0
0
1112
9625
3.85
27.54
29.9
18.3
139.5
139.8
mmol/l
2.77
1093
9348
1112
9645
3.81
27.02
30.3
18.4
4.0
4.0
mmol/l
0.53
1092
9355
788
5921
2.00
26.80
5.9
4.1
2.7
2.8
ug/l
0.05
704
5271
621
4327
1.92
26.19
7.1
5.4
1.2
1.2
mmol/l
0.54
558
3819
255
1293
2.24
26.09
7.5
6.3
105.2
104.3
mmol/l
2.31
250
1252
214
1023
2.33
25.10
5.0
3.4
—
—
—
0
0
32
41
8.00
23.49
1.5
1.2
—
—
—
0
0
1117
9864
3.64
23.24
36.8
21.5
237.9
231.7
e9/l
2.51
1090
9522
1117
9866
3.63
23.19
36.9
21.5
4.4
4.5
e12/l
6.28
1088
9474
1117
9868
3.63
23.14
37.1
21.7
132.5
137.1
g/l
16.44
1101
9649
401
2514
1.90
22.46
7.1
3.8
0.0
0.0
estimate
0.50
179
729
301
1713
2.02
22.40
2.0
1.8
—
—
—
0
0
437
2846
1.85
21.53
3.2
2.3
54.4
58.5
u/l
1.67
410
2595
66
181
3.80
21.18
4.2
1.8
73.8
44.0
u/ml
0.23
57
142
844
6744
1.89
20.86
4.4
4.1
16.1
12.8
mm/h
5.63
751
6142
158
730
2.35
19.80
4.6
3.4
5.1
5.1
kpa
0.22
149
668
1084
9564
2.71
19.68
13.1
9.5
25.4
26.5
u/l
1.04
1042
9095
151
691
2.36
19.32
4.4
3.4
1.1
1.8
mmol/l
1.45
118
487
156
727
2.32
19.14
1.9
2.0
0.2
0.2
g/l
2.55
142
647
570
4127
1.74
18.90
2.5
2.2
—
—
—
0
0
388
2564
1.77
17.41
2.5
2.2
3.2
3.0
mg/l
0.80
328
2152
138
636
2.33
17.32
1.9
1.6
—
—
—
0
0
421
2854
1.74
17.23
4.0
2.0
2.3
2.3
mmol/l
0.07
352
2325
912
7657
1.85
16.98
25.5
16.4
39.0
39.5
%
0.60
523
4610
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
89
356
2.62
15.13
4.2
2.9
0.3
0.3
u/ml
0.30
53
205
231
1361
1.87
14.85
3.1
2.6
18.4
22.8
%
5.68
195
1148
241
1442
1.84
14.75
3.0
2.5
2.3
2.2
g/l
1.31
217
1329
62
207
3.11
14.69
1.5
1.5
—
—
—
0
0
40
102
4.02
14.23
2.1
1.7
419.6
56.4
u/ml
0.45
35
93
88
366
2.52
13.81
3.5
3.0
—
—
—
0
0
173
953
1.96
13.56
6.9
6.8
10.8
11.6
mmol/l
0.76
163
895
843
7098
1.66
13.45
31.3
17.7
14.0
13.8
%
6.18
829
6905
230
1396
1.81
13.31
3.9
2.7
0.8
0.8
mmol/l
0.58
214
1281
468
3458
1.59
12.72
3.3
2.8
162.1
164.4
ug/l
0.07
411
3126
184
1064
1.86
12.40
3.3
2.6
221.9
239.9
u/l
2.74
174
990
211
1274
1.80
12.36
6.6
5.4
1.0
1.0
mmol/l
0.15
198
1172
249
1578
1.73
12.34
3.1
2.5
10.8
12.6
umol/l
3.48
229
1440
90
402
2.34
12.09
2.1
1.5
—
—
—
0
0
928
8099
1.69
11.96
4.8
4.2
2.0
2.0
mu/l
1.25
796
7184
606
4795
1.54
11.91
5.2
3.9
20.7
24.1
%
7.46
347
2435
158
890
1.90
11.51
2.7
2.4
8.6
10.2
umol/l
0.26
143
776
442
3292
1.55
11.25
3.5
2.8
0.7
0.8
ug/l
0.21
335
2340
114
579
2.07
11.16
5.6
7.1
24.1
24.8
mmol/l
1.14
114
574
1011
9087
1.80
11.09
5.7
5.2
6.3
6.2
mmol/l
1.42
876
8098
36
102
3.61
11.08
1.2
1.2
—
—
—
0
0
194
1195
1.75
10.51
1.8
1.8
—
—
—
0
0
649
5295
1.50
10.49
3.2
3.0
58.0
54.9
u/l
0.30
592
4773
38
117
3.32
10.33
3.7
2.8
0.7
1.5
%
0.78
25
80
91
438
2.17
10.24
2.4
1.6
—
—
—
0
0
191
1194
1.72
9.78
1.7
1.8
—
—
—
0
0
126
698
1.90
9.63
2.6
2.1
31.5
39.6
u/l
0.60
110
575
352
2580
1.52
9.26
1.6
1.6
19.2
19.7
nmol/l
0.25
289
2145
134
768
1.84
9.21
4.5
3.1
1.2
1.2
mmol/l
0.62
112
656
750
6394
1.48
9.12
4.0
3.3
15.1
15.0
pmol/l
0.10
631
5632
120
666
1.89
9.11
8.3
8.5
1.2
1.4
%
0.87
120
660
119
659
1.90
9.10
8.4
8.6
0.5
0.7
%
4.10
119
652
451
3514
1.46
8.63
3.3
3.2
2431.6
1769.1
ng/l
0.97
400
3028
38
132
2.94
8.49
1.3
1.3
9.1
7.1
u/l
0.63
30
111
989
9013
1.61
8.14
5.1
5.0
4.2
4.3
mmol/l
1.70
860
8207
241
1671
1.56
8.04
3.9
2.1
2.5
2.4
mmol/l
3.65
214
1422
98
531
1.92
8.01
8.9
8.9
23.6
24.3
mmol/l
1.88
93
492
436
3417
1.44
7.92
2.1
2.1
79.7
77.5
nmol/l
0.72
362
2931
536
4364
1.42
7.86
2.2
2.1
91.6
92.0
pmol/l
0.08
298
2349
67
318
2.17
7.84
3.7
3.1
24.1
24.9
mmol/l
0.66
59
280
166
1059
1.66
7.81
4.3
3.5
1.1
2.0
mmol/l
2.21
126
838
113
649
1.82
7.71
1.6
1.5
—
—
—
0
0
111
635
1.83
7.67
1.6
1.5
—
—
—
0
0
1007
9256
1.61
7.55
5.7
5.6
2.4
2.5
mmol/l
2.10
873
8393
349
2643
1.46
7.54
3.1
2.7
46.6
45.8
u/l
0.02
322
2489
235
1647
1.53
7.42
31.0
30.5
1.4
1.5
inr
0.55
42
230
966
8804
1.54
7.42
7.7
6.8
42.1
41.4
mmol/mol
1.42
864
8032
188
1260
1.59
7.22
7.1
6.8
0.2
1.2
mmol/l
3.14
152
967
188
1262
1.58
7.17
7.1
6.8
12.0
11.4
kpa
1.02
180
1204
188
1262
1.58
7.17
7.1
6.8
5.0
5.1
kpa
0.29
181
1204
507
4136
1.40
7.13
5.3
4.1
44.2
73.7
ng/l
1.41
434
3211
464
3730
1.40
7.11
4.3
4.1
10.9
7.7
mg/mmol
0.62
321
2470
447
3573
1.40
7.07
3.3
3.2
7.5
7.9
mmol/l
1.63
351
2956
254
1827
1.50
7.07
1.7
1.6
1.7
1.3
mg/l
0.82
200
1412
975
8932
1.54
7.02
5.0
4.9
1.3
1.4
mmol/l
4.03
840
8068
60
287
2.15
6.92
1.6
1.7
—
—
—
0
0
116
695
1.74
6.87
2.1
2.2
10.2
15.0
nmol/l
9.24
100
589
117
708
1.72
6.69
3.6
1.7
351.0
363.0
nmol/l
0.22
111
630
197
1360
1.54
6.62
2.9
2.0
1.7
1.7
%
0.02
177
1184
31
111
2.84
6.62
1.1
1.1
—
—
—
0
0
83
459
1.87
6.40
2.0
1.7
1.2
1.9
ug/l
0.58
73
401
51
236
2.21
6.40
2.6
2.5
15.4
16.3
%
0.69
27
129
945
8647
1.47
6.39
4.6
4.4
1.4
1.3
mmol/l
3.48
806
7734
86
502
1.77
5.60
4.7
4.0
23.5
24.3
mmol/l
1.56
74
436
340
2712
1.36
5.11
3.1
2.7
6845.7
7429.4
umol/l
0.06
269
2287
32
136
2.39
4.93
1.9
1.7
88.9
89.9
%
0.43
32
136
273
2118
1.38
4.85
4.4
4.1
468.9
487.3
ng/l
0.03
235
1847
49
252
1.99
4.74
2.3
2.2
123.5
132.8
g/l
1.19
36
190
10
21
4.79
4.53
5.4
1.4
87.4
71.8
nmol/l
—
10
21
23
87
2.68
4.50
3.1
2.9
63.8
58.5
%
0.34
12
53
25
99
2.56
4.48
1.5
1.3
—
—
—
0
0
16
49
3.30
4.48
1.1
1.2
24.0
21.2
iu/l
0.16
11
44
18
60
3.03
4.41
1.2
1.3
13.5
11.0
u/l
0.40
18
55
23
89
2.62
4.32
1.1
1.4
—
—
—
0
0
85
534
1.64
4.28
1.6
1.6
1.7
1.5
g/l
1.73
77
447
22
86
2.59
4.06
4.7
2.5
—
—
—
0
0
57
326
1.79
4.04
2.9
3.2
4.3
4.4
pmol/l
0.37
52
273
27
117
2.34
4.03
1.4
1.6
27750.8
81090.1
e6/l
0.54
17
75
389
3264
1.29
3.90
2.5
2.2
208.2
258.0
u/l
0.41
357
3044
36
184
1.99
3.61
2.4
2.2
214.9
198.3
%
0.48
36
174
59
354
1.70
3.57
2.2
2.2
199.9
96.4
ug/min
0.37
33
213
41
223
1.87
3.45
1.3
1.4
—
—
—
0
0
41
223
1.87
3.45
1.3
1.4
—
—
—
0
0
25
113
2.24
3.43
1.5
1.8
326.8
266.3
mu/l
0.27
25
104
7
10
7.03
3.36
1.0
1.0
—
—
—
0
0
113
806
1.44
3.25
3.3
2.4
57.8
61.8
ml/min/173m2
0.54
49
325
9
19
4.76
3.24
1.3
1.4
—
—
—
0
0
258
2098
1.29
3.22
7.8
3.9
1.0
1.0
kg/l
0.10
39
326
36
193
1.89
3.18
1.6
1.7
—
—
—
0
0
287
2373
1.28
3.14
1.8
1.7
428.7
28295392.2
pmol/l
1.92
216
1912
43
246
1.78
3.11
1.2
1.5
—
—
—
0
0
26
125
2.10
3.10
1.5
1.6
1539.9
1794.4
e6/l
0.18
20
88
39
217
1.82
3.08
1.4
1.5
216.4
277.5
ug/g
1.12
21
135
29
146
2.01
3.07
2.5
2.1
4.2
4.2
mmol/l
0.13
29
146
29
146
2.01
3.07
2.5
2.1
107.7
105.3
mmol/l
1.72
29
146
15
56
2.70
3.06
1.2
1.1
—
—
—
0
0
6
9
6.69
2.87
1.3
1.1
—
—
—
0
0
22
103
2.16
2.82
1.7
1.6
—
—
—
0
0
53
333
1.62
2.76
3.9
1.5
1.1
1.4
ratio
—
6
27
54
341
1.61
2.75
3.8
1.5
83.9
36.0
mg/l
1.03
39
274
54
342
1.61
2.72
3.8
1.5
56.7
53.3
mg/l
0.14
39
273
270
2256
1.26
2.68
1.9
1.8
1125.4
1151.5
nmol/l
0.17
188
1694
44
272
1.64
2.47
1.2
1.3
—
—
—
0
0
43
269
1.62
2.32
3.9
2.9
1.6
1.7
mmol/l
0.40
43
262
17
80
2.14
2.19
2.4
1.8
1.1
1.2
u/field
—
8
29
40
250
1.62
2.18
4.0
3.0
7.5
7.6
mmol/l
0.11
40
243
7
19
3.70
2.15
1.3
1.5
43.9
29.9
%
—
7
14
8
25
3.21
2.09
5.4
2.7
—
—
—
0
0
9
32
2.83
2.00
8.2
1.9
—
—
—
0
0
15
70
2.16
1.98
2.3
1.7
—
—
—
0
0
5
11
4.56
1.94
1.0
1.2
5.5
1.5
umol/l
—
5
11
24
135
1.79
1.92
1.5
1.4
—
—
—
0
0
16
78
2.07
1.91
1.3
1.5
—
—
—
0
0
28
166
1.70
1.88
1.5
1.4
—
—
—
0
0
26
151
1.74
1.88
5.2
7.6
7.4
7.8
mmol/l
0.25
21
121
5
12
4.18
1.82
2.6
2.6
—
—
—
0
0
113
891
1.30
1.82
2.6
1.6
66.0
66.8
g/l
0.55
101
798
9
35
2.58
1.80
2.2
1.4
—
—
—
0
0
99
773
1.31
1.72
1.2
1.3
—
—
—
0
0
5
13
3.86
1.71
2.6
2.5
—
—
—
0
0
92
713
1.31
1.69
4.7
3.9
107.5
98.3
ng/l
0.36
76
613
0
49
0.00
1.68
0.0
1.0
—
—
—
0
0
12
56
2.15
1.61
1.2
1.4
—
—
—
0
0
12
56
2.15
1.61
1.2
1.4
—
—
—
0
0
13
63
2.08
1.60
1.2
1.4
—
—
—
0
0
159
1328
1.23
1.60
5.0
5.1
32.9
32.7
%
0.11
99
864
6
21
2.87
1.50
1.5
1.2
—
—
—
0
0
20
116
1.74
1.49
1.5
2.3
825.8
631.4
ml
—
8
73
137
1137
1.23
1.47
2.9
2.5
6.3
8.2
ug/l
0.69
121
985
22
132
1.68
1.46
1.2
1.1
1.0
16.2
iu/ml
—
5
25
31
205
1.53
1.41
1.7
1.5
—
—
—
0
0
17
96
1.78
1.39
1.3
1.2
—
—
—
0
0
9
41
2.20
1.37
2.7
1.5
—
—
—
0
0
71
549
1.31
1.37
5.3
3.6
48.5
47.3
%
0.15
71
540
32
216
1.49
1.34
1.8
1.5
—
—
—
0
0
17
98
1.75
1.31
1.3
1.2
—
—
—
0
0
17
98
1.75
1.31
1.3
1.2
—
—
—
0
0
35
243
1.45
1.29
1.7
1.6
1.4
11.7
iu/ml
—
9
53
10
48
2.09
1.28
3.1
3.7
—
—
—
0
0
33
227
1.47
1.27
5.5
3.6
29.9
30.6
mg/l
0.04
21
145
54
406
1.35
1.27
1.3
1.4
—
—
—
0
0
21
131
1.61
1.24
1.7
1.5
—
—
—
0
0
46
341
1.36
1.19
1.3
1.7
37.3
38.6
u/l
0.20
37
277
8
38
2.11
1.18
1.5
1.2
—
—
—
0
0
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
8
38
2.11
1.18
1.5
1.2
—
—
—
0
0
22
141
1.57
1.17
1.5
1.4
61.8
68.8
%
0.31
13
89
16
94
1.71
1.17
1.3
1.2
—
—
—
0
0
5
20
2.51
1.15
1.2
1.1
—
—
—
0
0
16
95
1.69
1.14
1.3
1.2
—
—
—
0
0
23
151
1.53
1.12
1.9
1.5
—
—
—
0
0
26
176
1.49
1.11
1.1
1.4
—
—
—
0
0
16
96
1.68
1.10
2.2
1.2
—
—
u/ml
—
0
0
16
96
1.68
1.10
1.3
1.2
—
—
—
0
0
7
31
2.27
1.10
3.3
2.0
44.0
55.5
ug/l
—
7
31
21
138
1.53
1.03
3.8
3.3
58.7
59.0
%
0.02
21
138
55
431
1.29
1.01
4.3
4.1
1.3
1.4
mmol/l
0.28
55
422
18
115
1.57
1.00
3.1
4.1
—
—
—
0
0
9
50
1.81
0.96
1.4
1.2
—
—
—
0
0
20
133
1.51
0.94
1.2
1.3
—
—
—
0
0
9
51
1.77
0.94
1.4
1.2
—
—
—
0
0
7
37
1.90
0.94
2.0
2.5
—
—
—
0
0
7
37
1.90
0.94
2.0
2.5
—
—
—
0
0
90
755
1.21
0.93
7.4
6.9
24.3
24.5
mmol/l
0.18
85
704
20
134
1.50
0.92
3.4
3.1
5.3
4.6
e9/l
0.61
20
134
277
2535
1.12
0.91
1.6
1.6
1.4
1.3
mmol/l
1.02
212
2069
12
71
1.70
0.89
1.0
1.0
—
—
—
0
0
21
147
1.44
0.80
1.2
1.3
—
—
—
0
0
6
33
1.82
0.79
1.0
1.7
1628.8
987.5
u/ml
—
6
33
8
48
1.67
0.79
1.0
1.0
—
—
—
0
0
27
199
1.37
0.78
1.6
1.6
10.8
12.3
mg/l
0.34
21
181
19
131
1.46
0.78
1.7
2.4
13.2
19.8
mg/l
—
5
29
34
261
1.31
0.77
3.0
3.2
0.8
0.8
nmol/l
0.05
28
206
6
34
1.77
0.76
6.0
5.6
13.3
13.4
%
—
6
34
9
53
1.70
0.75
1.0
1.0
—
—
—
0
0
25
186
1.35
0.70
1.2
1.2
—
—
—
0
0
49
400
1.23
0.70
3.3
1.4
3.2
3.1
g/l
0.33
35
321
45
364
1.25
0.70
4.1
1.5
1.2
0.5
g/l
0.76
33
313
52
428
1.22
0.69
3.2
1.4
3.9
3.9
g/l
0.04
35
318
52
428
1.22
0.69
3.2
1.4
—
—
—
0
0
52
428
1.22
0.69
3.2
1.4
7.5
7.5
g/l
0.07
35
325
16
226
0.70
0.67
1.3
1.2
—
40.7
—
0
10
35
278
1.27
0.64
1.5
1.6
—
—
—
0
0
32
252
1.28
0.63
1.5
1.6
—
—
—
0
0
26
199
1.31
0.62
1.2
1.2
49.9
20.5
u/l
0.56
26
173
33
409
0.80
0.58
2.0
1.9
—
—
—
0
0
16
115
1.40
0.56
1.3
1.2
—
—
—
0
0
11
73
1.51
0.56
1.1
1.2
—
—
—
0
0
8
55
1.46
0.56
2.5
2.4
—
—
—
0
0
6
37
1.62
0.55
1.3
3.2
—
—
—
0
0
38
314
1.22
0.52
1.3
1.3
—
—
—
0
0
10
67
1.50
0.49
1.6
2.5
—
—
—
0
0
15
111
1.36
0.46
1.5
1.3
98.9
101.7
u/ml
—
7
15
7
49
1.43
0.46
1.3
1.5
203.9
66.7
pmol/l
—
7
49
119
1087
1.11
0.45
3.6
3.1
301.5
247.9
ng/l
0.56
110
1022
47
404
1.17
0.44
3.4
1.4
10.4
10.8
g/l
0.30
36
344
21
166
1.27
0.43
1.2
1.4
—
—
—
0
0
163
1519
1.08
0.42
1.2
1.2
2.0
1.7
u/ml
0.12
32
409
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
40
343
1.17
0.40
1.1
1.2
158.4
127.4
iu/ml
—
9
133
9
66
1.37
0.38
1.6
1.4
—
—
—
0
0
5
36
1.39
0.38
1.0
1.1
—
24.8
u/ml
—
0
5
5
37
1.35
0.37
2.0
1.1
—
—
—
0
0
5
37
1.35
0.37
2.0
1.1
—
—
—
0
0
5
37
1.35
0.37
2.0
1.1
—
—
—
0
0
5
37
1.35
0.37
2.0
1.1
—
—
—
0
0
16
125
1.28
0.37
1.2
1.1
—
—
—
0
0
17
134
1.27
0.37
1.5
1.2
—
23.3
—
0
5
16
201
0.79
0.35
1.8
1.3
1072.7
818.9
e6/l
0.09
11
170
16
201
0.79
0.35
1.7
1.3
17.3
44.8
e6/l
—
10
166
15
117
1.29
0.35
1.1
1.2
285.5
292.0
u/ml
—
6
65
6
43
1.40
0.35
1.2
1.4
—
10.8
u/l
—
0
18
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
44
1.37
0.34
1.2
1.2
—
—
—
0
0
19
232
0.82
0.34
1.3
1.3
754.5
516.7
mg/l
0.63
19
212
16
199
0.80
0.33
1.3
1.3
4.0
4.0
mmol/l
0.06
16
181
33
284
1.17
0.33
1.7
1.6
13948.3
16514.2
e6/l
0.22
23
208
14
177
0.79
0.33
1.3
1.1
—
16.2
—
0
15
12
154
0.78
0.32
1.2
1.2
—
—
—
0
0
41
363
1.13
0.29
4.9
4.5
4.0
4.0
mmol/l
0.07
34
332
8
66
1.21
0.26
1.0
1.1
—
11.5
nmol/l
—
0
17
14
113
1.24
0.26
1.1
1.0
1.4
1.6
g/l
0.85
14
98
5
75
0.67
0.26
2.0
1.2
—
—
—
0
0
5
75
0.67
0.26
2.0
1.2
—
—
—
0
0
5
75
0.67
0.26
2.0
1.2
—
—
—
0
0
36
321
1.13
0.24
4.1
1.4
0.4
0.0
g/l
0.60
31
297
27
237
1.14
0.23
1.1
1.2
—
—
—
0
0
12
97
1.24
0.23
1.3
1.2
1.2
1.5
nmol/l
0.59
12
85
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
5
40
1.25
0.22
2.6
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
19
219
0.87
0.20
1.4
1.4
1.2
0.8
nmol/l
1.00
12
178
38
345
1.10
0.20
4.0
1.4
35.8
37.4
g/l
0.74
29
293
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
11
90
1.22
0.19
1.5
1.4
—
—
—
0
0
33
299
1.11
0.18
1.1
1.2
—
—
—
0
0
33
299
1.11
0.18
4.4
1.4
0.0
0.0
g/l
0.00
28
276
121
1265
0.95
0.18
1.2
1.2
5.5
12.6
u/ml
1.24
32
449
7
61
1.15
0.17
1.1
1.1
2.3
2.0
mmol/l
—
7
56
134
1287
1.05
0.17
1.2
1.3
23.0
39.6
iu/ml
1.56
36
382
24
268
0.89
0.17
4.1
1.7
—
—
—
0
0
26
235
1.11
0.16
1.1
1.2
—
—
—
0
0
10
84
1.19
0.14
1.0
1.4
—
200.0
—
0
9
26
283
0.92
0.12
1.1
1.0
—
—
—
0
0
11
127
0.86
0.12
1.0
1.0
—
—
—
0
0
20
219
0.91
0.11
1.5
1.7
—
—
—
0
0
5
44
1.14
0.10
1.2
1.4
—
—
—
0
0
5
44
1.14
0.10
1.2
1.4
—
—
—
0
0
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
6
56
1.07
0.08
1.0
2.6
—
—
—
0
0
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
8
74
1.08
0.07
1.0
1.0
—
—
—
0
0
7
85
0.82
0.07
1.7
1.3
—
—
—
0
0
8
90
0.89
0.06
1.8
1.3
—
—
—
0
0
83
811
1.03
0.05
1.2
1.7
1.7
1.7
%
0.24
66
672
19
178
1.07
0.05
1.1
1.1
—
—
—
0
0
10
91
1.10
0.04
1.3
1.2
14.0
6.6
u/ml
—
5
48
10
91
1.10
0.04
1.7
1.6
—
2064.0
—
0
5
13
122
1.07
0.02
1.5
1.5
—
—
—
0
0
26
268
0.97
0.02
1.2
1.8
43.0
45.4
nmol/l
0.24
26
249
10
94
1.06
0.01
1.1
1.1
—
—
—
0
0
23
232
0.99
0.00
2.4
2.8
32.4
37.3
umol/l
0.37
16
199
140
1397
1.00
0.00
8.2
7.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
9
92
0.98
0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
9.3
—
0
6
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
19
190
1.00
0.00
1.4
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
14.1
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_OTHER_NOS_EXALLC – Carcinoma in situ of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).